海目星(688559.SH)擬使用募集資金2億元向江蘇海目星進行增資
格隆匯 10 月 19日丨海目星(688559.SH)公佈,公司2020年10月19日召開第二屆董事會第一次會議、第二屆監事會第一次會議,審議通過了《關於使用募集資金向全資子公司增資以實施募投項目的議案》,同意公司使用募集資金2億元向全資子公司海目星激光智能裝備(江蘇)有限公司(“江蘇海目星”)進行增資,其中3000萬元作為江蘇海目星註冊資金,剩下1.7億元作為江蘇海目星的資本公積。
此次增資後,江蘇海目星註冊資本由1.5億元變更為1.8億元,同時修訂江蘇海目星的公司章程,辦理工商變更登記,並由江蘇海目星實施上述募投項目。江蘇海目星將根據募投項目的實施進度,分階段投入募集資金,並對募投項目實施單獨建賬核算,以提高募集資金的使用效率。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.